TABLE OF CONTENTS
Detailed Table of Contents
Chapter 1 — Executive Summary
1.1Market Overview
1.22025 Market Size and 2035 Forecast
1.3Largest and Fastest-Growing Segments
1.4Key Country and Regional Highlights
1.5Competitive Positioning
1.6Strategic Recommendations
Chapter 2 — Research Scope and Methodology
2.1Market Definitions and Boundaries
2.2Base Year and Forecast Period
2.3Primary Research
2.4Secondary Research
2.5Bottom-Up Market Estimation
2.6Top-Down Market Estimation
2.7Data Triangulation
2.8Forecast Assumptions and Limitations
Chapter 3 — Market Dynamics
3.1Growth Drivers
3.2Market Restraints
3.3Growth Opportunities
3.4Industry Challenges
3.5Emerging Trends
3.6Porter’s Five Forces
3.7Value Chain and Pricing Analysis
Chapter 4 — Technology, Regulatory and Commercial Landscape
4.1Technology Evolution
4.2Product Innovation and Pipeline
4.3Regulatory Approvals and Compliance
4.4Clinical and Performance Evidence
4.5Reimbursement and Payer Access
4.6Distribution and Procurement
4.7Digital Integration and Interoperability
Chapter 5 — Market Size and Forecast, 2025–2035
5.1Market Revenue, 2025–2035
5.2Year-on-Year Growth and CAGR
5.3Revenue by Segment
5.4Largest Segment and Growth Rationale
5.5Fastest-Growing Segment and Growth Rationale
5.6Forecast Scenarios and Sensitivities
Chapter 6 — Market Analysis, by Modality
6.1Overview and Market Definition
6.2Revenue and Forecast, 2025–2035
6.3Subsegment Analysis
6.3.1X-ray: Analog, Digital Radiography, Fluoroscopy
6.3.2Computed Tomography: Low, Mid and High Slice
6.3.3Magnetic Resonance Imaging: Low, Mid and High Field
6.3.4Ultrasound: 2D, 3D/4D and Doppler
6.3.5Nuclear Imaging: PET, SPECT
6.3.6Mammography
6.3.7Other Modalities
6.4Largest Subsegment: Share and Drivers
6.5Fastest-Growing Subsegment: CAGR and Drivers
6.6Competitive and Commercial Implications
Chapter 7 — Market Analysis, by Application
7.1Overview and Market Definition
7.2Revenue and Forecast, 2025–2035
7.3Subsegment Analysis
7.3.1Cardiology
7.3.2Oncology
7.3.3Neurology
7.3.4Orthopedics
7.3.5Obstetrics and Gynecology
7.3.6Other Applications
7.4Largest Subsegment: Share and Drivers
7.5Fastest-Growing Subsegment: CAGR and Drivers
7.6Competitive and Commercial Implications
Chapter 8 — Market Analysis, by End User
8.1Overview and Market Definition
8.2Revenue and Forecast, 2025–2035
8.3Subsegment Analysis
8.3.1Hospitals
8.3.2Diagnostic Imaging Centers
8.3.3Ambulatory Care
8.3.4Other End Users
8.4Largest Subsegment: Share and Drivers
8.5Fastest-Growing Subsegment: CAGR and Drivers
8.6Competitive and Commercial Implications
Chapter 9 — Regional and Country Market Analysis
9.1Regional Market Share and Forecast, 2025–2035
9.2North America
9.2.1United States
9.2.2Canada
9.2.3Mexico
9.3Europe
9.3.1Germany
9.3.2United Kingdom
9.3.3France
9.3.4Italy
9.3.5Spain
9.3.6Netherlands
9.3.7Switzerland
9.3.8Nordic Countries
9.3.9Rest of Europe
9.4Asia Pacific
9.4.1China
9.4.2Japan
9.4.3India
9.4.4South Korea
9.4.5Australia
9.4.6Southeast Asia
9.4.7Rest of Asia Pacific
9.5Latin America
9.5.1Brazil
9.5.2Argentina
9.5.3Chile
9.5.4Colombia
9.5.5Rest of Latin America
9.6Middle East & Africa
9.6.1Saudi Arabia
9.6.2United Arab Emirates
9.6.3South Africa
9.6.4Turkey
9.6.5Rest of Middle East & Africa
9.7Largest Geography and Underlying Drivers
9.8Fastest-Growing Geography and Underlying Drivers
Chapter 10 — Competitive Landscape
10.1Competitive Structure
10.2Market Share and Concentration
10.3Product and Technology Benchmarking
10.4Pricing and Distribution Benchmarking
10.5Mergers and Acquisitions
10.6Partnerships and Collaborations
10.7New Product Launches
10.8Geographic Expansion
Chapter 11 — Company Profiles
11.1GE HealthCare
11.1.1Company Overview
11.1.2Relevant Product and Service Portfolio
11.1.3Financial Performance (Where Disclosed)
11.1.4Geographic Presence
11.1.5Recent Strategic Developments
11.1.6SWOT and Competitive Positioning
11.2Siemens Healthineers
11.2.1Company Overview
11.2.2Relevant Product and Service Portfolio
11.2.3Financial Performance (Where Disclosed)
11.2.4Geographic Presence
11.2.5Recent Strategic Developments
11.2.6SWOT and Competitive Positioning
11.3Philips
11.3.1Company Overview
11.3.2Relevant Product and Service Portfolio
11.3.3Financial Performance (Where Disclosed)
11.3.4Geographic Presence
11.3.5Recent Strategic Developments
11.3.6SWOT and Competitive Positioning
11.4Canon Medical Systems
11.4.1Company Overview
11.4.2Relevant Product and Service Portfolio
11.4.3Financial Performance (Where Disclosed)
11.4.4Geographic Presence
11.4.5Recent Strategic Developments
11.4.6SWOT and Competitive Positioning
11.5Fujifilm Healthcare
11.5.1Company Overview
11.5.2Relevant Product and Service Portfolio
11.5.3Financial Performance (Where Disclosed)
11.5.4Geographic Presence
11.5.5Recent Strategic Developments
11.5.6SWOT and Competitive Positioning
11.6United Imaging Healthcare
11.6.1Company Overview
11.6.2Relevant Product and Service Portfolio
11.6.3Financial Performance (Where Disclosed)
11.6.4Geographic Presence
11.6.5Recent Strategic Developments
11.6.6SWOT and Competitive Positioning
11.7Samsung Medison
11.7.1Company Overview
11.7.2Relevant Product and Service Portfolio
11.7.3Financial Performance (Where Disclosed)
11.7.4Geographic Presence
11.7.5Recent Strategic Developments
11.7.6SWOT and Competitive Positioning
11.8Hologic
11.8.1Company Overview
11.8.2Relevant Product and Service Portfolio
11.8.3Financial Performance (Where Disclosed)
11.8.4Geographic Presence
11.8.5Recent Strategic Developments
11.8.6SWOT and Competitive Positioning
11.9Shimadzu
11.9.1Company Overview
11.9.2Relevant Product and Service Portfolio
11.9.3Financial Performance (Where Disclosed)
11.9.4Geographic Presence
11.9.5Recent Strategic Developments
11.9.6SWOT and Competitive Positioning
11.10Mindray
11.10.1Company Overview
11.10.2Relevant Product and Service Portfolio
11.10.3Financial Performance (Where Disclosed)
11.10.4Geographic Presence
11.10.5Recent Strategic Developments
11.10.6SWOT and Competitive Positioning
Chapter 12 — Appendix
12.1Market Definitions and Acronyms
12.2Currency and Exchange Rate Assumptions
12.3Forecast Modeling Notes
12.4Source and Data Limitations
12.5Research Disclaimer